ATLASCogent Biosciences (COGT) earnings date: Nov 6, 2026
Cogent Biosciences (COGT) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026. Analysts expect EPS of -$0.57.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on COGT
| Last price | $31.02 (-2.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.7% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Cogent Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Cogent Biosciences reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Cogent Biosciences. You can switch it off at any time.
Alert me before COGT reportsFree to start. Creating an account takes under a minute.
COGT earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.57 |
| Last report | Aug 10, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +32.2% |
| Average move around a report | ±5.1% (last 5) |
| Sector | Healthcare · Biotechnology |
Cogent Biosciences earnings history: last 5 reports
Cogent Biosciences last reported on Aug 10, 2026: EPS of -$0.52 against an estimate of -$0.56 (+7.1% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.56 | -$0.52 | +7.1% | Beat | -8.7% |
| May 5, 2026 | -$0.54 | -$0.53 | +1.9% | In line | -2.3% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | +0.6% |
| Feb 17, 2026 | -$0.51 | -$0.56 | -9.8% | Miss | +5.0% |
| Jan 13, 2026 | $1.36 | $1.52 | +11.8% | Beat | +8.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for COGT
See the fair value, the probability range and the earnings history of Cogent Biosciences on its ATLAS page.
Cogent Biosciences (COGT) stock analysisPlans from €3.99 a month.
Cogent Biosciences earnings: frequently asked questions
When does Cogent Biosciences (COGT) report earnings?
Cogent Biosciences is scheduled to report on Friday, November 6, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for COGT?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.57 per share (USD). Estimates can change before the report.
How often does COGT beat earnings estimates?
Of its last 5 reports with a recorded result, Cogent Biosciences beat the EPS estimate 3 times; the average surprise was +32.2%. Past results do not predict the next one.
How much does COGT move around earnings?
Over its last 5 reports the stock moved an average of 5.1% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Cogent Biosciences beat earnings estimates last quarter?
Cogent Biosciences last reported on Aug 10, 2026: EPS of -$0.52 against an estimate of -$0.56 (+7.1% surprise), a beat.
How much does COGT usually move in a day?
On a normal trading day the ATLAS model puts COGT’s one-day range at about ±2.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer